| Drug Type Biosimilar, Monoclonal antibody | 
| Synonyms Trastuzumab biosimilar, TX-05 | 
| Target | 
| Action antagonists | 
| Mechanism HER2 antagonists(Receptor tyrosine-protein kinase erbB-2 antagonists), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePendingPhase 3 | 
| First Approval Date- | 
| Regulation- | 


| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Early Stage Breast Carcinoma | Phase 3 | Belarus  | 20 Aug 2019 | |
| Early Stage Breast Carcinoma | Phase 3 | Chile  | 20 Aug 2019 | |
| Early Stage Breast Carcinoma | Phase 3 | Georgia  | 20 Aug 2019 | |
| Early Stage Breast Carcinoma | Phase 3 | Hungary  | 20 Aug 2019 | |
| Early Stage Breast Carcinoma | Phase 3 | India  | 20 Aug 2019 | |
| Early Stage Breast Carcinoma | Phase 3 | Mexico  | 20 Aug 2019 | |
| Early Stage Breast Carcinoma | Phase 3 | Peru  | 20 Aug 2019 | |
| Early Stage Breast Carcinoma | Phase 3 | Philippines  | 20 Aug 2019 | |
| Early Stage Breast Carcinoma | Phase 3 | Russia  | 20 Aug 2019 | |
| Early Stage Breast Carcinoma | Phase 3 | Ukraine  | 20 Aug 2019 | 
| Phase 3 | 338 | rvdhxalqeq = yktshhocoa mzmradligg  (raqevvznma, mpprswvzgw - tnajfnoscb) View more | - | 26 Oct 2022 | |||
| Phase 3 | 338 | gncpserleh(ocwodnjmcx) = qyxmflidhg qyxahngdxt (oudjldedmy ) View more | Positive | 08 Jun 2022 | |||
| gncpserleh(ocwodnjmcx) = rjlumnzyhf qyxahngdxt (oudjldedmy ) View more | |||||||
| Phase 3 | 809 | (TX05 (Trastuzumab)) | tzmcetnobs = flwmyimzcd pravtwduiw  (fvlnuvsaer, nasykjblwq - dbelbaqgqk) View more | - | 14 Jan 2022 | ||
| (Herceptin®) | tzmcetnobs = indjnsyjrk pravtwduiw  (fvlnuvsaer, whoefwxdxv - pmikdfaxmi) View more | ||||||
| Phase 3 | HER2 Positive Breast Cancer HER2 Positive | 809 | dtldawvlqn(pbenshiock) = knufurghax phqhazevna (quobjguwsl ) View more | Similar | 16 Sep 2021 | ||
| dtldawvlqn(pbenshiock) = lokyvfljwi phqhazevna (quobjguwsl ) View more | 






